Back to results
US 9,868,703 B2Granted
PRMT1 inhibitors and uses thereof
AssigneeEpizyme, Inc.
InventorsKevin Wayne Kuntz, Lorna Helen Mitchell, Gideon Shapiro, Richard Chesworth, Paula Ann Boriack-Sjodin
Life of this patent
Estimating the term…
Abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting PRMT1 activity. Methods of using the compounds for treating PRMT1-mediated disorders are also described.
Claims2
A compound that is
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.